Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Health
Vandana Singh

BMO Capital Cuts Price Target On HCA Healthcare

BMO Capital has lowered the price target on HCA Healthcare Inc (NYSE:HCA) to $250 from $275 while keeping the Market Perform rating on the shares after its Q4 results. 

  • Analyst Matt Borsch notes execution was very strong, but HCA still contends with near-term issues that include uneven volumes, staffing constraints, and related wage and other inflation.
  • The analyst also adds that the Q4 results are likely to continue to be volatile.
  • Related: HCA Healthcare Q4 Earnings Lag Estimates, Issues FY22 Guidance.
  • After the earnings, Cowen lowered the price target from $302 to $265 and kept an Outperform rating on the shares. 
  • The analyst updated his model by slightly lowering its EBITDA for 2022, 2023, and 2024 due to COVID costs/occupancy and deferred surgical recovery labor costs.
  • Price Action: HCA shares are up 1.55% at $240.26 during the market session on the last check Monday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.